[Asia Economy Reporter Yoo Hyun-seok] Daebong LS, a company specializing in cosmetic materials and active pharmaceutical ingredients, announced on the 16th that it recorded consolidated third-quarter sales of 17.7 billion KRW, operating profit of 2.4 billion KRW, and net profit of 2.1 billion KRW. These represent increases of 6.6%, 42.7%, and 31.9% respectively compared to the same period last year.
On a cumulative basis, the company achieved sales of 59 billion KRW, operating profit of 8.2 billion KRW, and net profit of 6.8 billion KRW, marking increases of 15.8%, 46.5%, and 33.2% respectively compared to the same period last year.
A company representative stated, “Sales of disinfectant and antibacterial raw materials have significantly increased due to the COVID-19 pandemic, and the strong performance of our subsidiary, P&K Skin Clinical Research Center, is reflected in these results. We will do our best to finish this year well and repay all stakeholders with good outcomes.”
Daebong LS plans to complete a smart production facility and research center by the end of next year on a 9,633.4㎡ site (Songdo-dong 210-5) within the Songdo Advanced Industrial Cluster, consisting of two basement floors and five above-ground floors.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
